These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19896222)

  • 1. BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide.
    Matsumoto Y; Kobata T; Odaka M; Furukawa K; Hirata K; Yuki N
    J Neuroimmunol; 2010 Jan; 218(1-2):67-72. PubMed ID: 19896222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies.
    Perera VN; Nachamkin I; Ung H; Patterson JH; McConville MJ; Coloe PJ; Fry BN
    FEMS Immunol Med Microbiol; 2007 Jun; 50(1):27-36. PubMed ID: 17374131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Anti-GT1a Antibodies with an Outbreak of Guillain-Barré Syndrome and Analysis of Ganglioside Mimicry in an Associated Campylobacter jejuni Strain.
    Zhang M; Gilbert M; Yuki N; Cao F; Li J; Liu H; Li Q; Meng F; Zhang J
    PLoS One; 2015; 10(7):e0131730. PubMed ID: 26197476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
    Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
    PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
    Koga M; Takahashi M; Yokoyama K; Kanda T
    J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
    Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
    Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
    Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for antecedent Campylobacter jejuni infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy.
    van Eijk JJ; van Alfen N; Tio-Gillen AP; Maas M; Herbrink P; Portier RP; van Doorn PA; van Engelen BG; Jacobs BC
    J Peripher Nerv Syst; 2011 Jun; 16(2):153-6. PubMed ID: 21692917
    [No Abstract]   [Full Text] [Related]  

  • 14. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
    Koga M; Gilbert M; Li J; Yuki N
    PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
    Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
    Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
    Ang CW; Noordzij PG; de Klerk MA; Endtz HP; van Doorn PA; Laman JD
    Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
    Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
    J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
    Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
    J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.